# Point 11: The Kidnapped Test Subjects

## CLASSIFIED — INTERNAL DISTRIBUTION ONLY ### NeoCortex Industries — Human Resources Allocation Division ### Document Class: OBSIDIAN / Eyes-Only / Non-Discoverable ### Revision 14.2 — Last Updated Φ3 2198

---

> *"The advancement of neural science requires a subject population that reflects real-world variance. Controlled laboratory conditions, paired with participants who carry no prior systemic entanglements, produce the cleanest possible data. This is not exploitation. This is methodology."* > — Dr. Elise Seo, Chief Research Ethics Compliance Officer, NeoCortex Industries, Annual Shareholder Letter 2194

---

## 1. THE PIPELINE

### 1.1 Acquisition Framework

All human test material is sourced through the **Voluntary Contribution Program (VCP)**, a multi-channel acquisition system operating across seven corponation territories and fourteen ungoverned zones. The VCP is subdivided into four operational tracks, each managed by a dedicated procurement team within the Human Resources Allocation Division (HRAD).

**Track A — Community Integration Initiative (CII)**

Operates in ungoverned zones and climate displacement corridors. Field teams establish temporary aid stations offering food, medical screening, and shelter registration. Participants who complete intake processing are assigned a CII identification number, which simultaneously enrolls them in Phase Zero candidacy. Transport to "integration housing" follows within 48 hours. No integration housing exists. The buses go to intake facilities.

CII field stations currently operate in: - Great Lakes Reclamation Fringe (Chicago-Milwaukee corridor, ungoverned sections) - Gulf Coast Displacement Zone (former Houston-Galveston metropolitan area) - Eastern Seaboard Flood Settlements (New Jersey marshlands, unincorporated) - Pacific Northwest Exclusion Perimeter (Portland collapse zone)

Quarterly throughput: 800-1,200 individuals per corridor.

**Track B — Employment Opportunity Placement (EOP)**

Targets working-age individuals in economically collapsed municipal zones. Recruitment advertisements — posted on public boards, distributed by paid local intermediaries, and broadcast on unlicensed mesh networks — offer manufacturing, logistics, or agricultural positions with NeoCortex subsidiary companies. Positions include housing, meals, and a modest salary payable in NeoCortex CreditScript.

Applicants report to regional processing centers for "onboarding medical evaluation." Those who meet research criteria (age, health baseline, neural plasticity markers) are flagged in the system as **Neural Development Candidates (NDC)** and diverted from the employment track.

The remaining applicants receive legitimate job placements. This is important. The pipeline must produce real employees at a predictable ratio to maintain cover integrity. Current guidance: no more than 1 in 8 applicants may be diverted. Regional managers who exceed this ratio are flagged for operational security review.

**Track C — Institutional Transfer Protocol (ITP)**

Formal partnerships with municipal detention systems, psychiatric commitment facilities, and state child welfare agencies in jurisdictions where oversight has functionally ceased. Subjects are transferred under standardized documentation:

- **From prisons:** "Rehabilitation Through Research Partnership" agreements. Prisoners are offered sentence reduction in exchange for participation in "wellness studies." Consent forms are presented. Most sign. The ones who don't sign are transferred anyway, under a medical authority override clause embedded in the partnership contract. - **From psychiatric facilities:** Patients deemed "non-responsive to available treatment" are transferred to "advanced neurological care programs." Facility administrators receive per-patient payments ranging from Φ4,000-Φ12,000 depending on the patient's neural health profile. - **From child welfare:** Orphans and wards of the state aged 8-17 are transferred under "Educational Placement Initiative" documentation. These subjects are classified internally as **Developmental Cohort** and are prioritized for long-duration longitudinal studies. Their youth provides optimal neural plasticity. Their files note that no family contacts exist to generate inquiry.

**Track D — Direct Acquisition (DA)**

The least preferred but most efficient track. NeoCortex Security Division conducts targeted extractions in ungoverned zones, displacement camps, and areas of civil unrest. Operations are disguised as law enforcement sweeps, disaster relief evacuations, or corponation border enforcement actions.

Direct Acquisition teams operate under Rules of Engagement document HRAD-DA-7, which specifies: - No operations within sovereign corponation territory (jurisdictional exposure risk) - No operations within functioning municipal police zones (witness risk) - Maximum extraction window of 90 minutes per operation - All subjects sedated within 4 minutes of acquisition - Transport vehicles bear municipal emergency services livery or humanitarian organization markings

DA operations account for approximately 15% of total subject intake but carry the highest operational security cost. They are authorized only when specific research programs require demographic profiles that passive acquisition tracks cannot fill — typically healthy adults aged 20-40 with no prior BCI exposure and no detectable genetic anomalies.

### 1.2 The Language

Internal communications follow a mandatory lexicon established by HRAD Operational Security Directive 11-C. The following terms are standard across all documentation, correspondence, and verbal communication:

| Internal Term | Meaning | |---|---| | Phase Zero Participant | Test subject | | Neural Development Candidate | Subject flagged for BCI experimentation | | Voluntary Contributor | Any acquired subject, regardless of acquisition method | | Community Integration | Abduction from ungoverned zone | | Onboarding | Intake processing at a testing facility | | Wellness Study | Any experimental procedure | | Graduation | Subject death | | Early Release | Subject disposal (living but non-functional) | | Data Yield Event | Successful extraction of research data from a subject, regardless of subject outcome | | Resource Allocation | Decision on whether to continue or terminate a subject's participation | | Contribution Complete | Subject has been fully utilized and is no longer generating data |

Personnel who use non-standard terminology in written communications receive a single warning. A second violation results in reassignment to a non-classified division with a mandatory non-disclosure reinforcement session.

---

## 2. WHO GETS TAKEN

### 2.1 Primary Demographics

The ideal Phase Zero Participant shares a single defining characteristic: **no one will look for them.**

HRAD maintains a tiered classification system based on acquisition risk:

**Tier 1 — Zero Exposure Risk (preferred)** - Exclusion Registry members (individuals formally stripped of legal identity by one or more corponations; see *Ringo v. Tallow* precedent). No government records, no corporate records, no biometric enrollment in any functioning system. These individuals do not exist in any database. They cannot file complaints, access legal counsel, or be reported missing, because no system recognizes them as present. - Undocumented climate migrants from collapsed coastal zones, wet-bulb displacement corridors, and agricultural failure regions. Estimated 400 million globally as of 2198. No census captures them. They move in currents, not addresses. - Orphans with no surviving registered family. Specifically, children whose parents were themselves unregistered — second-generation invisibility.

**Tier 2 — Minimal Exposure Risk** - Homeless populations in ungoverned zones. High attrition rates in these populations mean disappearances are expected and unremarked. - The chronically mentally ill, particularly those with no treatment history in any functioning medical system. Their behavior patterns make their testimony inherently dismissible even if they escape. - Prisoners serving sentences in jurisdictions where the corrections system has been partially or fully privatized and record-keeping has degraded. Transfer paperwork is trivially fabricated.

**Tier 3 — Moderate Exposure Risk (requires authorization)** - Dissidents and protestors flagged by predictive behavioral analysis systems. NeoCortex's Sentinel platform identifies individuals whose communication patterns, social connections, and movement data suggest future anti-corporate organizing activity. These individuals are pre-emptively acquired before they build networks that would notice their absence. Sentinel flags approximately 200 individuals per quarter across all monitored zones; of these, roughly 30-50 meet Phase Zero criteria. - Refugees from active conflict zones, particularly those in transit between camps. The chaos of mass displacement provides cover. Families separated during transit rarely reconnect. - Gig workers and day laborers in the informal economy — people whose employment is never recorded, whose landlords don't keep leases, whose social connections are shallow and transactional.

**Tier 3+ — Elevated Exposure Risk (requires HRAD Director approval)** - Any individual with a functioning corporate identity in any corponation system. - Any individual with verified family connections to employed or registered persons. - Any individual under active municipal law enforcement monitoring.

Tier 3+ acquisitions are rare and reserved for cases where a specific genetic profile, neural architecture, or medical history is required by a Priority One research program. These subjects are acquired under staged death protocols — vehicle accidents, building collapses in unstable zones, drowning incidents in flood corridors. A body is not always necessary. In displacement zones, people vanish without explanation as a matter of course.

### 2.2 Selection Criteria

Not everyone acquired enters testing. Intake facilities conduct a 72-hour evaluation including:

- Full neuroimaging (structural MRI, functional connectivity mapping, white matter tractography) - Genetic screening (full genome sequence, epigenetic methylation profile, mitochondrial haplotype) - Baseline cognitive battery (processing speed, working memory, executive function, pain sensitivity threshold) - Immune function panel - Psychological profile (stress response, suggestibility index, dissociative tendency score)

Subjects who fail minimum criteria are classified as **Non-Viable** and processed through one of three channels: 1. Released into an ungoverned zone at least 200 kilometers from the intake facility 2. Transferred to a NeoCortex subsidiary for non-research manual labor 3. Retained as control subjects (no experimental intervention, monitored for baseline data only)

Non-Viable subjects are administered a targeted amnestic compound (NeoCortex Pharma product NC-7741, trade name "SoftReset") that produces 72-96 hours of retrograde amnesia. Compliance rate with amnesia protocol: 94%. The remaining 6% retain fragmentary memories that are functionally indistinguishable from psychotic episodes or trauma-induced confabulation.

---

## 3. THE FACILITIES

### 3.1 Facility Classification

NeoCortex operates research installations under a four-tier classification system:

**SURFACE — Type S Facilities**

Located within or adjacent to legitimate NeoCortex operations. Typically occupy dedicated floors or wings within corporate research campuses, accessible only through biometric-locked service corridors not appearing on building schematics filed with municipal authorities.

Current Type S installations: - S-04 "Lakeview" — Sublevel 3-7 beneath NeoCortex Neurological Research Campus, Milwaukee Sovereign Zone. Capacity: 200 subjects. Primary focus: BCI implantation trials. - S-09 "Meridian" — East wing, floors 14-16, NeoCortex Medical Tower, Chicago-Milwaukee Corridor. Disguised as long-term neurological care unit. Capacity: 80 subjects. Primary focus: cognitive manipulation and memory architecture research. - S-12 "Blanchard" — Converted warehouse complex, Detroit Reclamation Zone (operating under Ringo CorpoNation territorial license). Capacity: 350 subjects. Primary focus: bulk screening and gene modification trials.

**SUBSURFACE — Type U Facilities**

Underground installations beneath structures owned by NeoCortex subsidiaries, partner corponations, or municipal entities operating under contractual arrangements. Access via freight elevators, maintenance tunnels, or purpose-built shafts.

- U-01 "Cradle" — Beneath St. Ansgar Medical Center, a legitimate hospital in the Great Lakes Metropolitan Zone. Three subterranean levels, connected to the hospital's morgue via a service corridor. Subjects who die during testing are processed through the hospital's cremation system as "unclaimed deceased." Capacity: 120 subjects. Primary focus: invasive neural surgery, high-mortality procedures. - U-06 "The Quiet Room" — Beneath a decommissioned water treatment plant, Ohio Triangle region. Six levels. Entirely self-contained, including power generation, water recycling, and air filtration. Designed for experiments requiring complete environmental isolation. Capacity: 40 subjects in individual sealed chambers.

**OFFSHORE — Type M Facilities**

Marine installations operating in international waters or within corponation-claimed maritime zones.

- M-02 "Pillar" — Converted deepwater drilling platform, Lake Michigan, 60 kilometers from shore. Officially registered as a NeoCortex Environmental Monitoring Station. Capacity: 160 subjects. Primary focus: bioweapon exposure testing (requires spatial isolation for containment protocols). - M-05 "Undertow" — Submersible facility, Gulf of Mexico exclusion zone. Mobile. Surfaces for supply transfers on a rotating schedule. Capacity: 90 subjects. Primary focus: consciousness transfer research (requires electromagnetic isolation impossible to achieve on land).

**ORBITAL — Type O Facilities**

Located on NeoCortex-operated orbital platforms or within leased modules on multi-tenant stations. Subjects are transported via NeoCortex's private launch infrastructure under cargo manifests listing "biological research material."

- O-01 "Zenith" — Dedicated module on NeoCortex Orbital Research Platform HERMES-3, low Earth orbit. Capacity: 24 subjects. Primary focus: zero-gravity neural interface testing, microgravity effects on BCI integration. The most expensive per-subject facility in the network. Reserved for Priority One research only. - O-03 "Stillpoint" — Attached to a shared commercial station at L2. Capacity: 12 subjects. Primary focus: long-duration consciousness isolation experiments. Subjects at Stillpoint have been continuously monitored for up to 14 months in sensory deprivation conditions achievable only in orbital freefall.

### 3.2 Physical Environment

All facilities share common design principles established in HRAD Infrastructure Standard 6:

**Containment.** Subjects are housed in individual cells measuring 2.4 x 3.0 meters. Walls are reinforced polycarbonate over steel framing. Lighting is remotely controlled, full-spectrum, maintained at 4100K during wake cycles and extinguished during rest cycles (6 hours per 24-hour period). Temperature is held at 19C. Cells contain a sleeping platform, a waste unit, and a hydration port. No personal items.

**Monitoring.** Each cell is equipped with four high-resolution cameras (visible and infrared spectrum), two microphones, a passive millimeter-wave scanner for continuous body imaging, and a suite of ambient biosensors measuring heart rate, respiratory rate, skin conductance, and gross motor activity. In facilities conducting BCI research, subjects with active implants are additionally monitored via real-time neural telemetry.

**Sterility.** Research areas maintain ISO Class 5 cleanroom standards. Surgical suites are ISO Class 3. All personnel entering subject housing or research areas undergo full decontamination protocols. This is not for the subjects' benefit. Contamination introduces variables.

**No windows.** No clocks. No calendars. No access to any communication system. Subjects do not know where they are, what day it is, or how long they have been in the facility. Temporal disorientation is not an oversight. It is specified in the research protocol as a baseline condition. Subjects who can track time exhibit stress patterns that corrupt certain categories of neurological data.

---

## 4. WHAT'S DONE TO THEM

### 4.1 Program Categories

All experimentation falls under one of seven designated research programs. Each program carries its own protocol manual, success criteria, and acceptable loss thresholds.

**PROGRAM ATLAS — Experimental BCI Implantation**

The flagship program. Subjects receive prototype brain-computer interfaces that are 2-5 years from regulatory submission — devices too early in development for any process resembling legitimate clinical trials.

Current Atlas subprograms:

- **Atlas-9 (Threadweave):** Testing of ultra-high-density electrode arrays. Current generation: 12,288 electrodes across 512 threads, quadruple the density of any commercially available BCI. Surgical implantation requires removal of a 4cm x 6cm skull section and direct placement on cortical surface. No anesthesia is used during the final calibration phase, as pain response data is collected simultaneously. Procedure duration: 9-14 hours. - **Atlas-12 (DeepRoot):** Subcortical electrode placement — threading electrodes into the thalamus, hippocampus, and amygdala. Consumer BCIs interact with the cortical surface. DeepRoot goes deeper, targeting the structures that govern memory formation, emotional response, and sensory gating. Surgical mortality rate: 23%. Of survivors, 40% exhibit permanent personality alteration within 72 hours of implantation. - **Atlas-15 (WetLink):** Biological-synthetic hybrid interfaces. Rather than metal electrodes, WetLink uses engineered neural tissue grown from the subject's own stem cells, coaxed into forming connections between the brain's existing architecture and an external processing unit. When it works, the integration is seamless — the brain cannot distinguish the implant from itself. Current success rate for full integration: 4%. - **Atlas-17 (Firmware):** Subjects with stable implants from prior Atlas programs receive iterative firmware updates to test new signal processing algorithms, compression protocols, and neural codec architectures. Updates are pushed remotely. Subjects are not informed when an update occurs. Side effects have included seizures, temporary blindness, synesthetic episodes, involuntary motor activation, and in three cases, a state researchers describe as "cognitive whiteout" — a complete cessation of subjective experience lasting 30-90 seconds while the subject remains physically conscious and responsive to reflex testing.

**PROGRAM CHIMERA — Gene Modification Trials**

CRISPR-derived gene editing applied to living adult subjects. Unlike legitimate gene therapy, which targets specific genetic diseases, Chimera protocols modify functional genes in healthy tissue to test enhancement thresholds.

- **Chimera-3 (Ironclad):** Myostatin gene suppression combined with synthetic growth factor upregulation. Goal: sustained 40% increase in skeletal muscle density without exercise stimulus. Results: muscular hypertrophy achieved in 60% of subjects. However, 35% of responders develop cardiac hypertrophy leading to heart failure within 6 months. Subjects are maintained on life support as long as musculoskeletal data remains useful. - **Chimera-7 (Nightjar):** Retinal gene modification for enhanced low-light vision. Introduction of synthetic rhodopsin variants into rod cells. Successful subjects gain functional vision at 0.001 lux (equivalent to starlight). Failure mode: uncontrolled rhodopsin expression causing permanent photophobia and, in severe cases, phototoxic retinal destruction upon exposure to normal daylight. - **Chimera-11 (Methuselah):** Telomerase activation and senescent cell clearance in subjects aged 50+. The gerontological grail. Preliminary results suggest 15-20% reversal of certain aging biomarkers. The problem: uncontrolled cell proliferation. 4 of 22 subjects in the current cohort have developed aggressive, treatment-resistant cancers within 8 months of modification.

**PROGRAM GAUNTLET — Bioweapon Exposure Testing**

Conducted exclusively at offshore and orbital facilities. Subjects are exposed to engineered pathogens, neurotoxins, and synthetic prion agents to establish lethality curves, incubation timelines, and symptom progression data.

Gauntlet protocols require the least from subjects. They require only that the subject be alive, and then that they die in a clinically observable manner.

- **Gauntlet-2 (Crucible):** Aerosolized neurotoxin exposure at graduated concentrations. Subjects are placed in sealed chambers and exposed for controlled durations. Monitoring continues until cessation of all neurological activity. Average time from exposure to death at standard concentration: 4 hours 17 minutes. Data collected includes: respiratory function decline curve, motor control degradation timeline, cognitive function loss sequence, pain response persistence duration. - **Gauntlet-6 (Ember):** Synthetic prion agent testing. Engineered transmissible spongiform encephalopathy with accelerated onset. Natural prion diseases take years to manifest. NeoCortex BioDefense Division's engineered variant produces detectable neurological symptoms within 9-14 days. Subjects are maintained through full disease progression, which concludes in 30-60 days. Brain tissue is harvested at multiple stages for structural analysis. - **Gauntlet-9 (Threshold):** Immune system response mapping. Subjects receive graduated doses of engineered pathogens with known lethality profiles to establish minimum lethal dose, median lethal dose, and immune evasion characteristics. Each subject represents a single data point on a dose-response curve.

**PROGRAM REFLEX — Pain Threshold and Sensory Research**

Maps the human nervous system's response to stimuli at intensities beyond any ethical research framework. The purpose is calibration data for neural weapon systems — devices designed to incapacitate through targeted pain induction via BCI-adjacent broadcast technology.

- Electrical stimulation of peripheral nerves at graduated intensity - Thermal exposure (both extremes) to establish tissue damage onset thresholds by body region - Chemical pain induction via capsaicin analogs, bradykinin, and synthetic nerve growth factor - Sustained stimulation protocols lasting 8-72 hours to map adaptation, sensitization, and psychological collapse thresholds

All Reflex subjects receive Atlas-series BCI implants to enable direct neural recording of pain signal propagation. The data is cross-referenced with subjective pain reporting (subjects are required to verbally rate their pain on a continuous scale throughout all procedures). Discrepancies between neural recording and subjective report are themselves a research output — they map the threshold at which the brain ceases accurately reporting its own suffering.

**PROGRAM MIRROR — Cognitive Manipulation**

Explores the degree to which human thought, belief, memory, and identity can be externally modified through BCI-mediated intervention.

- **Mirror-1 (Revision):** Targeted memory erasure. Specific autobiographical memories are identified via neural imaging, and the associated engram networks are disrupted through precisely targeted electrical stimulation. Current precision: 70% of targeted memories successfully degraded. Collateral damage to adjacent memories: 15-30% of cases. - **Mirror-4 (Insertion):** False memory implantation. Synthetic experiential data — fabricated events, relationships, skills — is introduced through BCI-mediated stimulation of hippocampal and cortical networks during sleep cycles. Success is measured by the subject's subsequent behavior: do they act as though the implanted memory is real? Current full-conviction rate: 22%. - **Mirror-7 (Override):** Real-time behavioral control. BCI-mediated stimulation of motor cortex, supplementary motor area, and prefrontal regions to induce specific actions without the subject's conscious intent. The subject experiences the action as volitional. Current reliability: gross motor commands (stand, walk, stop) achieve 85% compliance. Fine motor commands (write a specific word, manipulate an object) achieve 35% compliance.

**PROGRAM EXODUS — Consciousness Transfer**

The most speculative and highest-mortality program. Attempts to map, copy, or transfer human consciousness between substrates — biological brain to digital storage, biological brain to biological brain, or biological brain to synthetic neural tissue.

- **Exodus-1 (Snapshot):** Full-brain activity recording at maximum resolution during the moment of death. Subjects with high-density Atlas implants are brought to the point of clinical death (cardiac arrest, respiratory cessation) while all neural activity is recorded. The subject is then resuscitated if possible. The recording is analyzed for patterns that might constitute a complete consciousness state. 60 subjects have undergone Snapshot protocols. 14 could not be resuscitated. The recordings show immense complexity but no one has determined what, if anything, has been captured. - **Exodus-4 (Bridge):** Direct neural-to-neural transfer. Two subjects with compatible Atlas implants are connected through a high-bandwidth bridge. Neural patterns from Subject A are amplified and transmitted to Subject B's cortex. Results are ambiguous. Subject B reports intrusive thoughts, fragmentary memories that are not their own, and emotional states inconsistent with their circumstances. In one case, Subject B began speaking in Subject A's regional dialect. In another, Subject B experienced Subject A's documented phobia of water despite having no personal history of water-related trauma. Subject A, in all cases, reports no change. What is being transferred — if anything — remains undefined.

**PROGRAM SENTRY — Neural Weapon Calibration**

Development and testing of directed-energy and broadcast-frequency systems designed to interfere with human neural function at range. Builds on Reflex program data.

- BCI-targeted electromagnetic pulse calibration (inducing seizure, unconsciousness, or disorientation in implanted individuals via remote signal) - Broadband neural disruption (affecting unimplanted individuals through transcranial stimulation at distance — current effective range: 15 meters) - Selective incapacitation (targeting specific neural functions — motor control, balance, vision — while leaving others intact)

All Sentry testing requires live subjects. Simulation cannot replicate the variance of human neuroanatomy. Each subject's unique neural architecture provides calibration data that improves targeting algorithms for the next iteration.

---

## 5. SUCCESS RATES AND FAILURES

### 5.1 The Mathematics

Across all programs, NeoCortex processes approximately 4,000-5,000 subjects per fiscal year. Outcomes are tracked in the **Participant Lifecycle Database (PLD)** under the following terminal classifications:

| Classification | Code | Definition | Annual % | |---|---|---|---| | Data Yield — Viable | DY-V | Subject survived with useful, reproducible data generated | 5.2% | | Data Yield — Terminal | DY-T | Subject died but generated useful data prior to or during death | 31.4% | | Partial Yield | PY | Some data generated but insufficient for program objectives | 18.7% | | Non-Yield Attrition | NY-A | Subject died or became non-functional before generating meaningful data | 28.3% | | Baseline Control | BC | Subject was not experimented upon; used for comparative data only | 12.1% | | Active — Ongoing | A-O | Subject is currently enrolled in an active protocol | 4.3% |

The number that matters: **5.2% survive with useful data.** Approximately 1 in 20.

Of that 5.2%, roughly half carry permanent impairment — neurological damage, sensory deficits, chronic pain, psychological conditions — that would be classified as catastrophic disability under any functioning medical system. They are "viable" only in the sense that the experiment they endured produced data that advanced a research objective.

### 5.2 Failure Modes

The 28.3% classified as Non-Yield Attrition — subjects who died or became non-functional without producing useful data — represent the system's primary inefficiency. Causes include:

- **Acute surgical mortality:** Death during or within 48 hours of an implantation or modification procedure. Most common in Atlas-12 (DeepRoot) and Exodus programs. These deaths often occur before any data collection begins, making them a pure loss from a research perspective. - **Rejection cascade:** The body's immune system attacks an implant or gene modification, triggering systemic inflammatory response. In BCI subjects, this manifests as progressive cerebral edema, leading to herniation and death over 3-14 days. - **Psychotic break:** Subjects experiencing cognitive manipulation (Mirror programs) or consciousness transfer (Exodus programs) who enter irreversible psychotic states. Neural data from psychotic subjects is considered contaminated — the brain is no longer functioning within normal parameters, so any data it generates is unrepresentative. - **Suicide:** Despite containment protocols, subjects find ways. The rate is highest among long-duration subjects (enrolled for more than 90 days) and subjects in Reflex programs. The PLD classifies these as "Self-Initiated Contribution Completion." - **Baseline health failure:** Subjects acquired from displacement zones and ungoverned areas arrive with undiagnosed conditions — malnutrition, parasitic infections, environmental toxin exposure, untreated chronic disease — that complicate or preclude experimental protocols.

### 5.3 Disposal Logistics

Subjects classified as Contribution Complete (dead or permanently non-functional) are processed through the **Terminal Resource Management (TRM)** system:

- **Biological material with research value** (brain tissue, modified organs, implant-tissue interface samples) is harvested, catalogued, and stored in the NeoCortex BioArchive at facility S-04. - **Implanted hardware** is recovered, inspected, and either refurbished for reuse or destructively analyzed. Atlas-series implants cost Φ180,000-Φ2.4 million per unit to manufacture. Hardware recovery is a budgetary line item, not a moral decision. - **Remains** are processed through cremation at partner facilities (see: U-01 "Cradle" / St. Ansgar Medical Center arrangement) or, for offshore and orbital installations, through chemical dissolution. - **Living non-functional subjects** — those with severe brain damage, irreversible psychosis, or catastrophic physical impairment who will generate no further data — are transferred to the **Sunset Ward** at facility S-12, where they receive minimal life-sustaining care until organ failure. Average duration in Sunset Ward: 47 days.

### 5.4 Accounting

In NeoCortex's financial systems, Phase Zero Participants are not classified as people. They are classified as **consumable research material**, budgeted under line item 4700-C ("Biological Test Substrates") alongside laboratory animals, cell cultures, and tissue samples.

Per-subject cost is calculated as:

> **Acquisition cost** (Track A: ~Φ200, Track B: ~Φ800, Track C: ~Φ2,000-Φ12,000, Track D: ~Φ35,000) > **+ Facility housing** (Φ120/day) > **+ Experimental materials** (procedure-dependent; Atlas implant procedures average Φ340,000 in materials alone) > **+ Disposal** (Φ1,800 average) > **= Total per-subject investment**

This figure is weighed against the **Data Value Index (DVI)** — a proprietary metric estimating the commercial value of data generated per subject. The DVI for a successful Atlas-series BCI trial subject ranges from Φ4 million to Φ22 million, depending on the novelty of findings and their proximity to a commercially viable product.

The math justifies everything. It always does.

---

## 6. THE CORPO JUSTIFICATION

### 6.1 The Internal Narrative

NeoCortex's executive leadership does not consider the VCP program to be unethical. This is not cognitive dissonance or willful denial. It is a coherent internal logic that operates as follows:

**"These subjects would have died anyway."**

Actuarial data on Exclusion Registry populations shows a median life expectancy of 34 years. Climate refugees in ungoverned zones: 41 years. Homeless populations in megalopolis fringe areas: 29 years. These numbers are cited in every annual program review. The implicit argument: a subject who dies at age 32 in a NeoCortex facility was statistically likely to die at age 34 in a drainage culvert. The facility death at least generates data that contributes to products benefiting millions of registered citizens.

**"The data saves millions."**

Atlas-series BCI research has directly produced three commercially approved neural interfaces currently used by 11 million patients worldwide for treatment of paralysis, treatment-resistant depression, and Alzheimer's symptom management. Chimera gene modification research contributed to four approved gene therapies. Gauntlet bioweapon data underpins the defensive countermeasures protecting 600 million people in NeoCortex-serviced territories. These numbers are real. The products are real. The people they help are real.

**"They signed consent forms."**

All Track B and Track C subjects sign consent documentation. The forms are 140 pages. They are written at a postgraduate reading level. They include, on page 94, paragraph 11(c), a clause authorizing "any and all neurological, physiological, genetic, or cognitive research procedures deemed necessary by the research team, including procedures carrying a risk of permanent impairment or death." Track A and Track D subjects receive consent forms post-acquisition. Refusal to sign is noted in the file but does not affect enrollment. The form's existence is the point, not its validity.

**"They have no legal standing."**

This is the foundation. Under the Exclusion Registry framework and the jurisdictional precedents established by cases like *Ringo v. Tallow*, individuals who exist outside all corporate and governmental identity systems have no mechanism to bring legal action. They cannot file suit because no court recognizes them as plaintiffs. They cannot report crimes because no law enforcement agency recognizes them as victims. They cannot be murdered because no jurisdiction recognizes them as alive.

NeoCortex's legal division has published a 300-page internal memorandum (document LG-2191-4455, "Legal Status of Unregistered Persons in Proprietary Research Contexts") concluding that no current law — federal, state, municipal, or corponation — criminalizes any action taken against a person who does not exist in any legal system. The memorandum has been updated annually since 2191. No court has ever tested its conclusions, because no one with standing has ever brought the challenge.

### 6.2 The People Who Make It Work

The VCP program employs approximately 2,200 people across all facilities. They are organized into tiers of knowledge:

- **Tier 1 (Full Knowledge):** HRAD executive leadership, facility directors, senior researchers, security division commanders. Approximately 80 individuals. They know everything. They attend annual program reviews where subject mortality statistics are presented alongside revenue projections. They receive performance bonuses tied to Data Value Index outputs. - **Tier 2 (Functional Knowledge):** Researchers, surgeons, lab technicians, facility security personnel. Approximately 600 individuals. They know the subjects are involuntary. They know the procedures are not approved by any regulatory body. They perform the work. Most have rationalized their participation through one or more of the justifications described above. Those who haven't rationalized it tend to develop substance dependency issues, which NeoCortex's employee health program treats discreetly and without notation in personnel files. - **Tier 3 (Compartmentalized Knowledge):** Field recruitment teams, transport personnel, intake processing staff, maintenance workers. Approximately 1,500 individuals. They know their piece. They do not know the full scope. A CII field team worker believes they are helping relocate displaced populations to housing facilities. A transport driver knows the buses go to a facility but not what happens inside. Compartmentalization is maintained through strict information barriers, physical separation of work areas, and a culture that does not reward curiosity.

All personnel across all tiers are themselves enrolled in the Exclusion Registry as a condition of employment — not as a punishment but as a security measure. If they talk, they become the same class of person as the subjects. They have no legal identity outside NeoCortex. They cannot quit without becoming no one.

---

## 7. THE SURVIVORS

### 7.1 Who Comes Out

Of the approximately 5.2% of subjects classified as DY-V (Data Yield — Viable), not all remain in the system permanently. Some are released. The reasons are practical:

**Unwitting Field Tests.** Subjects with stable experimental hardware — particularly Atlas-series BCI implants — are sometimes released into the general population to generate real-world performance data that cannot be replicated in a controlled environment. These subjects are fitted with monitoring packages that transmit telemetry to NeoCortex receiving stations. They do not know they are transmitting. They are told they have been selected for "early graduation" from a rehabilitation program. They are given a small amount of CreditScript, clothing, and a location to be dropped — typically an ungoverned zone far from the facility where they were held.

HRAD tracks 140 active field test subjects as of Φ3 2198. Average monitoring duration before telemetry hardware fails or the subject moves beyond receiving range: 14 months.

**Diminishing Returns.** Long-duration subjects whose data yield has plateaued but who are not non-functional. Keeping them is a cost. Disposing of them generates no further value. They are released under the same protocols as field test subjects, minus the monitoring package.

**Escapes.** It happens. Not often — the annual escape rate across all facilities is 0.3%, approximately 12-15 subjects per year — but containment is imperfect and human beings are resourceful in ways that security protocols cannot fully anticipate. Most escapees are recaptured within 72 hours. Those who are not recaptured are monitored remotely if they carry implants, and flagged in NeoCortex security systems for re-acquisition if they surface in a monitored zone.

A small number are never recovered. These are the ones the system worries about.

### 7.2 What They Carry

Every survivor emerges with some combination of the following:

**Hardware nobody else has.** A subject released from an Atlas-12 (DeepRoot) trial carries a subcortical BCI that won't reach the commercial market for three to five years. It interfaces with brain structures that no consumer device touches. Its capabilities — if the subject can learn to use them — exceed anything publicly available. But there is no user manual. No technical support. No firmware updates. No one to call when the implant glitches at 3 AM and the subject's left hand won't stop closing into a fist.

**Trauma that doesn't have a name.** No psychiatric framework accounts for what these subjects have experienced. They have been experimented on, but they weren't prisoners of war (no war was declared). They weren't victims of a crime (no crime was committed, legally). They weren't patients (no therapeutic intent existed). The experience exists in a category that the mental health system does not recognize. Most survivors present with symptom profiles that overlap with complex PTSD, but therapists — the rare ones who would treat an unregistered person — find that the standard frameworks don't map cleanly. The dissociative symptoms are complicated by the presence of actual hardware in the brain that mediates between the subject and their own cognition.

**Knowledge that makes them targets.** They know facility locations. They know program names. They know the faces of researchers. They know what NeoCortex is doing. This makes them a permanent security concern. HRAD Security maintains a **Priority Reacquisition List** of 34 former subjects currently at large who are assessed as possessing operationally sensitive knowledge. These individuals are tracked, and if they establish contact with journalists, advocacy organizations, or competing corponations, they are reacquired under Track D protocols.

**A body that isn't entirely theirs.** Gene modification subjects carry alterations that express continuously. A Chimera-7 (Nightjar) survivor sees in the dark and burns in daylight. A Chimera-3 (Ironclad) survivor carries muscle density that their skeleton wasn't built to support, and their heart is working too hard, and it won't stop. These modifications cannot be reversed. The subject lives with what was done to them, in the most literal physical sense, for whatever remains of their life.

### 7.3 The Ones Who Disappear Into the World

The most dangerous survivors, from NeoCortex's perspective, are those who integrate. Who find ways to exist in ungoverned zones or fringe communities. Who learn to use their hardware. Who build lives around what was done to them.

A DeepRoot survivor who masters their subcortical interface can do things that no legitimate BCI user can. They can read their own emotional states as data. They can modulate their fear response. Some report the ability to enter a cognitive state they describe as "clear" — a condition in which the implant's processing supplements their own, and they think faster, perceive more, react without the delay of conscious decision-making.

These individuals are, in a functional sense, prototypes. Walking proof-of-concept for technologies that NeoCortex will sell to paying customers in five years. And they were made without consent, without care, and without any intention that they survive.

Some of them are angry. Some of them remember everything.

---

## 8. THE RESISTANCE

### 8.1 Who Fights This

There is no organized, unified resistance to the VCP program, because the VCP program does not officially exist. What exists instead is a constellation of small, disconnected groups and individuals operating on fragments of knowledge.

**The Undertow Network**

A decentralized collective of roughly 200-400 individuals (estimates vary; the network is intentionally opaque) operating across the Great Lakes Metropolitan Zone and the Northeast Corridor. Undertow conducts three categories of operation:

- **Interception:** Identifying and disrupting Track A and Track B acquisition pipelines. Undertow operatives infiltrate CII aid stations and EOP recruitment events, warning potential subjects and providing counter-documentation that can, in some cases, establish enough of a paper identity to move an individual from Tier 1 (Zero Exposure) to Tier 3+ (Elevated Exposure Risk), making them too costly to acquire. - **Extraction:** Physically removing subjects from transport convoys between acquisition points and intake facilities. This is rare and extremely dangerous. NeoCortex transport security is armed. Undertow has conducted an estimated 7-12 successful extractions per year over the past four years. - **Aftercare:** Providing medical support, shelter, and psychological care to survivors and escapees. This is the bulk of what Undertow does. Most of their resources go to keeping people alive and hidden after they come out.

Undertow is not an army. It is a hospice, a safehouse network, and an early warning system held together by encrypted mesh communications and a shared understanding that what is being done must be witnessed, even if it cannot be stopped.

**Whistleblowers**

Eleven NeoCortex employees have attempted to disclose VCP program information to external parties since 2189. Their outcomes:

- 4 were identified during the planning phase by internal surveillance and terminated from employment. As per the employment security protocol, termination triggered their removal from all corporate identity systems, placing them on the Exclusion Registry. Two of these four were subsequently acquired as Phase Zero Participants themselves. - 3 successfully transmitted partial information to media organizations. In all three cases, the information was not published. Two outlets declined because the claims were unverifiable (the subjects and facilities described don't appear in any system). One outlet was owned by a NeoCortex media subsidiary and killed the story internally. - 2 reached independent journalists operating outside corponation media ecosystems. The resulting publications appeared on unlicensed mesh networks and were read by an estimated 8,000-15,000 people. NeoCortex's public relations division issued no denial (denying something confirms its existence). The stories circulated, were regarded by most readers as conspiracy theory, and decayed. - 1 transmitted facility coordinates and program documentation to a competing corponation (Zheng-Hauer BioSciences), apparently believing that corporate rivalry would force exposure. Zheng-Hauer used the intelligence to develop a competing research program. The whistleblower was found dead in an ungoverned zone three months later. Cause of death was listed as "environmental exposure" by local authorities who lacked jurisdiction to investigate further. - 1 is currently active and unidentified. HRAD Security designates this individual as **LEAKPOINT** and considers their identification a Priority One security objective. Internal communications analysis has narrowed the source to a pool of 40 Tier 2 personnel at facilities S-04 and U-01. Behavioral monitoring of all 40 is ongoing.

**The Moral Economy**

Fighting the VCP program means fighting something that produces no evidence, affects people who don't exist, operates in places that aren't on maps, and is conducted by a legal entity that has determined — with considerable legal rigor — that no crime is being committed.

Every tool of accountability requires that the victim be recognized as a person. The system is designed, from its foundations, to ensure they are not.

The people who fight it anyway do so knowing this. They do so knowing they cannot win in court, because courts don't hear cases brought by nobody. They cannot win in the press, because the press requires sources that exist. They cannot win through regulation, because the regulatory bodies that might once have intervened have been defunded, captured, or rendered jurisdictionally irrelevant by corponation sovereignty.

What remains is direct action — pulling people out of the pipeline one at a time — and witness. The act of knowing what is happening and refusing to look away, even when looking accomplishes nothing structural.

It is not enough. It is what there is.

---

## RELEVANCE TO STREETSAM URAI

The VCP pipeline is the machine that produces the street samurai. Not every survivor picks up a blade. But the ones who do carry hardware that makes them more than human, damage that makes them less than whole, and a relationship with the corponation system that is beyond grievance — it is ontological. They were made into what they are by an institution that classified them as consumable material. Their augmentations are not purchases or choices. They are scars that happen to function.

This intersects every facet:

- **WOUND** — The testing itself. The body that was opened, rewritten, and closed again by people who did not care whether it survived. The memories that may or may not have been altered. The inability to trust one's own cognition when the hardware mediating it was installed by someone else, for someone else's purposes. - **IDEAL** — The code that forms after. Some survivors adopt rigid personal ethics precisely because every ethical boundary was violated against them. The bushido of the street samurai may be a trauma response that happens to produce discipline. - **ID** — Who were they before? The VCP selects for people with no identity. The person who comes out must build an identity from scratch, with experimental hardware wired into the process of selfhood. - **SHADOW** — What the implant knows that they don't. The telemetry running in the background. The firmware they didn't install. The possibility that their thoughts are not entirely their own — not as metaphor, but as engineering reality. - **MASK** — The face they show the world. They cannot explain what happened to them. They cannot prove it. They carry technology that marks them as something other than baseline human, and no legitimate story explains how they got it. - **GHOST** — The deepest question. After DeepRoot, after Mirror, after Exodus — after the experiments that tampered with the structures of consciousness itself — are they still in there? Is the person who walks out of the facility the same person who was carried in? And if not, who is the one holding the sword?

---

*Filed under: Human Testing, VCP Program, Corporate Ethics, Exclusion Registry, Neural Research, Facility Operations*

*Cross-reference: Point 3 (Corponation Definition), Point 7 (BCI Trajectory), Point 9 (Exclusion Registry), Point 14 (Ringo v. Tallow)*